Answers are grounded in this paper and cite their sources.
A series of novel semisynthetic indole-fused taraxerone derivatives (2a–2f) were synthesised from taraxerone isolated from Rhizophora stylosa Griff. and characterised by 1H NMR,13C NMR, and HRMS analyses. Incorporation of the pharmacologically important indole moiety was aimed at enhancing protein-ligand interactions and antibacterial activity. The synthesised compounds, 2a–2f, were evaluated against Gram-positive bacteria (Lysinibacillus sp. and Bacillus circulans) and Gram-negative bacteria (Pseudomonas putida and Salmonella paratyphi). All derivatives exhibited notable antibacterial activity, with minimum inhibitory concentration (MIC) values ranging from 3.12 to 25 µg mL−1. Among them, compound 2e showed the highest potency, with an MIC of 3.12 µg mL−1, approximately two-fold more active than streptomycin sulphate (MIC = 6.25 µg mL−1). Molecular docking studies against the bacterial target protein (PDB ID: 5JZX) revealed favourable binding affinities for compounds 2d–2f. These results identify indole-fused taraxerone derivatives as promising leads for antibacterial drug development.
No takes yet. Share an insight, caveat, or question.
Vangara et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: